reference/8940024

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8940024

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase I\|Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	1816
issn	1460-2105 0027-8874
issueIdentifier	23
pageRange	1811-1816
publicationName	JNCI Journal of the National Cancer Institute
startingPage	1811
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8759cdcd947c85d95ad3585df75b702d
bibliographicCitation	Trump DL, Smith DC, Ellis PG, Rogers MP, Schold SC, Winer EP, Panella TJ, Jordan VC, Fine RL. High-Dose Oral Tamoxifen, a Potential Multidrug-Resistance-Reversal Agent: Phase I Trial in Combination With Vinblastine. JNCI Journal of the National Cancer Institute. 1992 Dec 02;84(23):1811–6. doi: 10.1093/jnci/84.23.1811.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc9589e0a18dbb875aefad9216e40f37 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_544a80684c98ec9a485432ca6ac9025a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_217bd844118075f786fd7f18f27d6e04 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2731cb021ee3941e090978b03fb8e9d6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2fbc8b21744ec58b5c85ac157643561 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_677b3c2856e559f81286c3690547d536 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8c2586af34cdd4dd4e4bc29ff4e67298 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b3d86f4887813464ef67013afaa761f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e52361ff6057956d365c51adfd7eba8
date	1992-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1093/jnci/84.23.1811 https://pubmed.ncbi.nlm.nih.gov/1359155
isPartOf	https://portal.issn.org/resource/ISSN/0027-8874 https://portal.issn.org/resource/ISSN/1460-2105 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4982
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	High-Dose Oral Tamoxifen, a Potential Multidrug-Resistance-Reversal Agent: Phase I Trial in Combination With Vinblastine
discusses	http://id.nlm.nih.gov/mesh/M0022672 http://id.nlm.nih.gov/mesh/M0014578 http://id.nlm.nih.gov/mesh/M0013336 http://id.nlm.nih.gov/mesh/M0021024 http://id.nlm.nih.gov/mesh/M0029890
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D009369Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D007262 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008562Q000187 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D020168 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D014747Q000008 http://id.nlm.nih.gov/mesh/D013629Q000008 http://id.nlm.nih.gov/mesh/D009363Q000187 http://id.nlm.nih.gov/mesh/D013629Q000009 http://id.nlm.nih.gov/mesh/D004351Q000502
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2b41adbd094947475b63355088c8b2f4 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9066 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241903 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3823887 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7620 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7205 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9480 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6025 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11104792 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6378383 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13342 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44417235 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10523 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6710780 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133126830 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10505 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129009934 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8355

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53789476

Total number of triples: 76.